PAS-004 in Patients With Advanced Solid Tumors

NCT06299839 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

RAS Mutation
NF1 Mutation
RAF Mutation
Advanced Solid Tumors

Interventions

DRUG: PAS-004 Capsules
DRUG: PAS-004 Tablets

Sponsor

Pasithea Therapeutics Corp.